Characteristics of human immunodeficiency virus-infected children at the time of death: An experience in the 1990s

Pediatric Infectious Disease Journal

Volumn 16, Issue 12, 1997, Pages 1145-1150

  Johann Liang, Rosemary ^a,b   Cervia, Joseph S ^a   Noel, Gary J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Children; Death; Human immunodeficiency virus; Mortality

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DIDANOSINE; ETHAMBUTOL; LAMIVUDINE; RIFABUTIN; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CHEMOPROPHYLAXIS; CHILD; CHILD DEATH; HEART FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PERINATAL INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; AGE FACTORS; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031454645     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199712000-00009     Document Type: Article

References (14)

1. Centers for Disease Control. AIDS among children: United States - 1996. MMWR 1996;45:1005-10.
2. Centers for Disease Control. US HIV and AIDS cases reported through December 1995. HIV/AIDS Surveillance Rep 1995;7 (No. 2).
3. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
4. Krasinski K, Borkowski W, Holzman RS. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr Infect Dis J 1989;8:216-20.
5. Barnhart HX, Caldwell MB, Thomas P, et al. Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the pediatric spectrum of disease project. Pediatrics 1996;97:710-16.
6. Kline MW, Bohannon B, Kozinetz CA, Rosenblatt HM, Shearer WT. Characteristics of human immunodeficiency virus-associated mortality in pediatric patients with vertically transmitted infections. Pediatr Infect Dis J 1992;11: 676-7.
7. The European Collaborative Study. Natural history of vertically acquired immunodeficiency virus-1 infection. Pediatrics 1994;94:815-9.
8. Duliege AM, Messiah A, Blanche S, Tardieu M, Griscelli C, Spira A. Natural history of human immunodeficiency virus type I infection in children: prognostic value of laboratory tests on the bimodal progression of the disease. Pediatr Infect Dis J 1992;11:630-5.
9. The European Collaborative Study. Age-related standards for T lymphocyte subsets based on uninfected children born to human immunodeficiency virus 1-infected women. Pediatr Infect Dis J 1992;11:1018-26.
10. Erkeller-Yuksel FM, Deneys V, Yuksel B, et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992;120:216-22.
11. Dibley MJ, Staehling NS, Nieburg P, Trowbridge FL. Interpretation of Z-score anthropometric indicators derived from the international growth reference. Am J Clin Nutr 1987;46: 749-62.
12. Sanders-Laufer D, DeBruin W, Edelson P. Pneumocystis carinii infections in HIV-infected children. Pediatr Clin North Am 1991;38:69-88.
13. Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with the human immunodeficiency virus. MMWR 1991; 40(RR-2):1-13.
14. Lewis L, Butler KM, Husson RN, et al. Defining the population of human immunodeficiency virus-infected children at risk for Mycobacterium avium-intracellulare infection. J Pediatr 1992;121:677-83.